Pressreleases

Chemoswed becomes Chemoswed

It has been broadly announced, that DuPont made a decision to separate the Performance Chemicals segment, creating two strong, independent companies by mid-2015.

Renewed GMP Certificate

Following inspections which took place late 2014, Chemoswed has received an updated certificate of GMP compliance. The certificate was issued by the Swedish Medical Products Agency, and covers all manufacturing facilities, i. e. kilolab, pilot plant, and the main manufacturing plant.

Custom Powder Systems: What We Do

We build equipment for food and pharmaceutical companies. When companies have problems, when they can't figure out what they need or where they need it, then we're the people that they call to come in and be their heroes. Have to figure out what they need and work with them on what the potential for their companies would be.

Benefits of the Integrated Containment Systems and Custom Powder Systems Partnership

Custom Powder and Integrated Containment Systems -- it's one stop shopping. They work with the same engineers, the same people. We're all communicating together with the same conference calls, so they're not having three other vendors involved. We explain all our problems, and then we speak amongst ourselves about how we can solve these problems so that it all works as smoothly as it does.

APCER Life Sciences Appoints Dr. Sutinder Bindra as Global Head of Medical Affairs, Opens Hong Kong Office

APCER Life Sciences, the truly global provider of safety, medical, regulatory, and technology services, announced today that Sutinder Bindra, MD, has joined the company as Global Head of Medical Affairs. Dr. Bindra, who was most recently Head of Medical and Clinical Affairs for Pfizer’s Asia-Pacific Region, will lead a fully integrated team to provide Medical Affairs services globally, including the Asia Pacific region, from APCER’s newly established office in Hong Kong.

Thomas Bachmann is new Chief Executive Officer of the Eppendorf Group

Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015. Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on an interim basis in addition to his responsibilities as CFO.

Medical Research Network Expands Global Reach with Six New Hires

The unique Clinical Trial Support Organisation (CTSO), Medical Research Network (MRN), which offers home trial and site nurse support, as well as bespoke recruitment and retention services, is set for further expansion after a host of new hires in the UK and US.

PRA Health Sciences, INC. Reports Second Quarter 2015 Results and Provides Updated Guidance for 2015

• $336.5 million of service revenue in the second quarter; 12% constant currency
growth compared to the second quarter of 2014. • $61.3 million of Adjusted EBITDA in the second quarter; 35% growth compared to the second quarter of 2014. • Second quarter Adjusted Net Income per share increased 37% to $0.47 per share and Adjusted Net Income increased 112% to $29.7 million compared to the second quarter of 2014. • Second quarter GAAP Net Income was $12.4 million or $0.20 per diluted share
Guidance for 2015 diluted Adjusted Net Income per share raised to $1.75-$1.85 from
$1.62-$1.72

Malvern Instruments Establishes new Biopharmaceutical Applications Laboratory in the Heart of San Diego’s Biotech Community

Malvern Instruments has established a new biopharmaceutical applications laboratory in the heart of San Diego’s biotechnology cluster. The new laboratory will enable customers and Malvern applications specialists alike to experience and use Malvern’s range of specialist biophysical characterization systems in a working biopharmaceutical environment.